603127 Stock Overview
Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.41 |
| 52 Week High | CN¥24.31 |
| 52 Week Low | CN¥12.32 |
| Beta | 0.67 |
| 1 Month Change | -7.59% |
| 3 Month Change | 27.55% |
| 1 Year Change | -25.53% |
| 3 Year Change | -68.92% |
| 5 Year Change | 19.43% |
| Change since IPO | 627.87% |
Recent News & Updates
Recent updates
Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) 28% Share Price Surge Not Quite Adding Up
Oct 01
Joinn Laboratories(China)Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Sep 03Joinn Laboratories(China)Co.Ltd (SHSE:603127) Is Reducing Its Dividend To CN¥0.16
Jul 28Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) Analysts Just Cut Their EPS Forecasts Substantially
Apr 08There May Be Reason For Hope In Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Disappointing Earnings
Apr 04Shareholder Returns
| 603127 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -1.4% | -1.5% | -1.2% |
| 1Y | -25.5% | -18.1% | 11.8% |
Return vs Industry: 603127 underperformed the CN Life Sciences industry which returned -18.1% over the past year.
Return vs Market: 603127 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 603127 volatility | |
|---|---|
| 603127 Average Weekly Movement | 8.6% |
| Life Sciences Industry Average Movement | 10.1% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603127 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603127's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,585 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
| 603127 fundamental statistics | |
|---|---|
| Market cap | CN¥11.81b |
| Earnings (TTM) | -CN¥912.86k |
| Revenue (TTM) | CN¥2.12b |
6.0x
P/S Ratio9,999x
P/E RatioIs 603127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603127 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.12b |
| Cost of Revenue | CN¥1.47b |
| Gross Profit | CN¥653.83m |
| Other Expenses | CN¥654.75m |
| Earnings | -CN¥912.86k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0012 |
| Gross Margin | 30.78% |
| Net Profit Margin | -0.043% |
| Debt/Equity Ratio | 0% |
How did 603127 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield-13,617%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 00:12 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Joinn Laboratories(China)Co.,Ltd. is covered by 22 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiangqiao Tong | BOCI Research Ltd. |
| Michael Meng | BOCI Research Ltd. |
| Linda Lu | BOCI Research Ltd. |